Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07616986
What this trial is testing

LITT for Ultra-early GBM Recurrence

Who this might be right for
Glioblastoma (GBM)Glioblastoma - Category
Insel Gruppe AG, University Hospital Bern 12
Early research (Phase 1)UnknownNCT04642937
What this trial is testing

Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
OX2 Therapeutics 24
Testing effectiveness (Phase 2)Study completedNCT01464177
What this trial is testing

Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme
Andre Tsin Chih Chen 40
Early research (Phase 1)UnknownNCT05108012
What this trial is testing

Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients

Who this might be right for
Glioblastoma MultiformRecurrent Glioblastoma
Royan Institute 5
Not applicableStudy completedNCT01342757
What this trial is testing

Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult GlioblastomaDepressionRecurrent Adult Brain Tumor
National Cancer Institute (NCI) 12
Early research (Phase 1)Looking for participantsNCT06455605
What this trial is testing

D2C7-IT + 2141-V11 Combination Post-resection in rGBM

Who this might be right for
Recurrent Glioblastoma IDH Wildtype
Darell Bigner 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT04221503
What this trial is testing

Niraparib/TTFields in GBM

Who this might be right for
GlioblastomaRecurrent GlioblastomaGBM
Abramson Cancer Center at Penn Medicine 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04910022
What this trial is testing

Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaDiffuse Glioma
Nerviano Medical Sciences 150
Early research (Phase 1)Not Yet RecruitingNCT07385846
What this trial is testing

Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency

Who this might be right for
GlioblastomaMismatch Repair Deficiency
Jennifer Leddon 8
Testing effectiveness (Phase 2)WithdrawnNCT05879120
What this trial is testing

Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
M.D. Anderson Cancer Center
Early research (Phase 1)UnknownNCT02844062
What this trial is testing

Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Beijing Sanbo Brain Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT02296476
What this trial is testing

A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)

Who this might be right for
Glioblastoma Multiforme
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 12
Not applicableStudy completedNCT01754350
What this trial is testing

Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Johann Wolfgang Goethe University Hospital 50
Early research (Phase 1)Active Not RecruitingNCT03152318
What this trial is testing

The Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

Who this might be right for
Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+11 more
Dana-Farber Cancer Institute 62
Testing effectiveness (Phase 2)Looking for participantsNCT06160206
What this trial is testing

Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

Who this might be right for
Recurrent GlioblastomaRecurrent WHO Grade 4 Glioma
Academic and Community Cancer Research United 134
Early research (Phase 1)UnknownNCT05700955
What this trial is testing

Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
University of Louisville 30
Not applicableLooking for participantsNCT05532397
What this trial is testing

Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma

Who this might be right for
Glioma, Astrocytic
National University Hospital, Singapore 10
Early research (Phase 1)Study completedNCT01851733
What this trial is testing

MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Washington University School of Medicine 37
Early research (Phase 1)Study completedNCT00509301
What this trial is testing

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme
Peregrine Pharmaceuticals 12
Early research (Phase 1)Study completedNCT03681028
What this trial is testing

Feasibility of Individualized Therapy for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Jennifer Clarke 30
Next Page